Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Furst

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|August 13, 2011
[Allogeneic hematopoietic stem cell transplantation in elderly]Luca Castagna, Didier Blaise, Sabine Furst
Emerging Infectious Diseases|August 21, 2020
Saprochaete clavata Outbreak Infecting Cancer Center through DishwasherEstelle Menu, Alexis Criscuolo, Marie Desnos-Ollivier, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center studyJean El Cheikh, Luca Castagna, Ling Wang, et al.
Bone Marrow Transplantation|July 15, 2021
A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantationSarah Cuvelier, Didier Blaise, Jean-Marie Boher, et al.
Leukemia & Lymphoma|July 5, 2013
National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimenColombe Saillard, Roberto Crocchiolo, Sabine Furst, et al.
Transplantation and Cellular Therapy|August 14, 2022
Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHDColombe Saillard, Pierre-Henri Legal, Sabine Furst, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
American Journal of Hematology|August 23, 2012
Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationJean El-Cheikh, Alberto Vazquez, Roberto Crocchiolo, et al.
Journal of Clinical Pharmacology|May 14, 2011
Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseasesChiara Piana, Linda Surh, Sabine Furst-Recktenwald, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|August 13, 2011
[Allogeneic hematopoietic stem cell transplantation in elderly]Luca Castagna, Didier Blaise, Sabine Furst
Emerging Infectious Diseases|August 21, 2020
Saprochaete clavata Outbreak Infecting Cancer Center through DishwasherEstelle Menu, Alexis Criscuolo, Marie Desnos-Ollivier, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center studyJean El Cheikh, Luca Castagna, Ling Wang, et al.
Bone Marrow Transplantation|July 15, 2021
A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantationSarah Cuvelier, Didier Blaise, Jean-Marie Boher, et al.
Leukemia & Lymphoma|July 5, 2013
National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimenColombe Saillard, Roberto Crocchiolo, Sabine Furst, et al.
Transplantation and Cellular Therapy|August 14, 2022
Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHDColombe Saillard, Pierre-Henri Legal, Sabine Furst, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
American Journal of Hematology|August 23, 2012
Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationJean El-Cheikh, Alberto Vazquez, Roberto Crocchiolo, et al.
Journal of Clinical Pharmacology|May 14, 2011
Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseasesChiara Piana, Linda Surh, Sabine Furst-Recktenwald, et al.
Pageof 5